NIH Study Tests Bone Marrow Stromal Cells From Multiple Tissues for Bone Regeneration
NIDCR researchers compared stromal cells from bone marrow, skin, spleen, and fat to identify which best regenerates bone and supports blood formation.
Summary
This terminated NIH clinical study aimed to determine whether stromal cells harvested from tissues beyond bone marrow — including skin dermis, spleen, thymus, and fat — could regenerate bone and support blood formation as effectively as traditional bone marrow stromal cells. Researchers collected small tissue specimens from surgical patients at Suburban Hospital in Bethesda, Maryland, grown stromal cells in the lab, and compared their genes, proteins, and functional capacities. The goal was to identify alternative, less invasive tissue sources for grafts used in healing bony defects and fractures. While the study was ultimately terminated before completion, the underlying question remains highly relevant to regenerative medicine: finding accessible, abundant stromal cell sources could transform how orthopedic surgeons and reconstructive specialists treat complex bone injuries without requiring painful bone marrow harvests.
Detailed Summary
Bone regeneration remains one of the most challenging problems in reconstructive surgery and orthopedics. Large bony defects from trauma, tumor removal, or infection often require grafts, and bone marrow stromal cells have long been considered the gold standard for stimulating new bone formation. However, harvesting bone marrow is invasive and painful, motivating researchers to explore whether equivalent cells exist in more accessible tissues.
This NIDCR-sponsored study recruited patients already undergoing surgery at Suburban Hospital in Bethesda, Maryland, in which bone, dermis, spleen, thymus, or fat tissue was incidentally removed. A small portion of each specimen — tissue that would have been sent to pathology anyway — was redirected for research. Stromal cells from each tissue type were isolated and cultured in the laboratory.
Researchers then compared the gene expression profiles and protein characteristics of stromal cells across tissue types, and tested each population's ability to form bone and support hematopoiesis (blood cell formation). The central hypothesis was that stromal cells from non-marrow tissues might share key functional properties with bone marrow stromal cells, potentially making them viable graft alternatives.
No results from this study have been published in the available record, and the trial was terminated before completion. The reasons for termination are not disclosed in the abstract. This limits any conclusions about which tissue sources, if any, proved comparable to bone marrow stromal cells in function.
Despite its terminated status, the study addresses a question that remains unresolved and clinically important. Identifying stromal cells in fat or skin that can regenerate bone would open the door to minimally invasive graft procurement, reducing patient burden. Subsequent research in mesenchymal stem cell biology has continued to explore this question with more refined methods and larger cohorts.
Key Findings
- Stromal cells from dermis, spleen, thymus, and fat were compared to bone marrow stromal cells for bone-forming potential.
- Study used surgical waste tissue, minimizing additional patient risk or invasiveness for specimen collection.
- Gene and protein profiles of stromal cells across tissue types were analyzed to identify functional equivalents.
- Trial was terminated; no published results are available, leaving the core hypothesis unresolved.
- Finding non-marrow stromal cell sources could reduce the need for painful bone marrow harvests in graft procedures.
Methodology
Observational tissue procurement study collecting surgical specimens from patients already undergoing bone, skin, spleen, thymus, or fat removal at Suburban Hospital, Bethesda. Isolated stromal cells were cultured in vitro and characterized by gene expression, protein profiling, and functional assays for osteogenesis and hematopoietic support. Sponsored by the National Institute of Dental and Craniofacial Research (NIDCR); registered on ClinicalTrials.gov as NCT00435877.
Study Limitations
The trial was terminated before completion and no results have been published, making it impossible to draw any conclusions about outcomes. This summary is based on the abstract and ClinicalTrials.gov registration only — full protocol details, enrollment numbers, and reasons for termination are unavailable. The study was conducted at a single center, which would have limited generalizability even had it been completed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.